1. Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer
   Stelios Chrysostomou et al, 2021, Science Translational Medicine CrossRef
2. Respiratory fluoroquinolones in the treatment of specific and non-specific lung diseases (literature review)
   E. Yakovleva et al, 2024, Vrach CrossRef
3. Comparative pharmacokinetics of levofloxacin in the saliva and blood plasma of patients with pneumonia
   Liudmila M. Krasnykh et al, 2021, Medical Journal of the Russian Federation CrossRef
4. Comparing the Therapeutic Potency of Camel Milk and Whey Protein Against Toxicity-Induced by Levofloxacin in Male Albino Rats
   Maram Musaed Alazzmi et al, 2023, Pakistan Journal of Biological Sciences CrossRef
5. Green Automated Solid Phase Extraction to Measure Levofloxacin in Human Serum via Liquid Chromatography with Fluorescence Detection for Pharmacokinetic Study
   Hager Ebrahim et al, 2023, Separations CrossRef
6. A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer
   Suhaila O. Alhaj-Suliman et al, 2023, Biomaterials CrossRef
7. Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin
   Kenji Tomizawa et al, 2022, Clinical Surgical Oncology CrossRef